Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Journal:
Current Neuropharmacology
Volume:
2
Page:
277-294
Author(s):
Jennifer K. Callaway
A1 Adenosine Receptor Agonists: Medicinal Chemistry and Therapeutic Potential
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2021-2039
Author(s):
S. A. Hutchinson and P. J. Scammells
Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2131-2143
Author(s):
Enriquez P and Bullock R.
Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2163-2176
Author(s):
O. L. Alves, W. P. Daugherty and M. Rios
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2177-2183
Author(s):
Anat Biegon
Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2185-2192
Author(s):
W. M. Armstead
Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2193-2204
Author(s):
J. Sahuquillo, M. P. Mena, A. Vilalta and M. A. Poca
Drug Therapy in Schizophrenia
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2205-2217
Author(s):
J. Ananth, S. Parameswaran and B. Hara
Antipsychotic Polypharmacy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2231-2238
Author(s):
J. Ananth, S. Parameswaran and Gunatilake
The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2239-2248
Author(s):
K. Burgyone, K. Aduri, J. Ananth and S. Parameswaran